* If you want to update the article please login/register
Despite low incidence, malignant urethral neoplasms are one of the most aggressive tumors. At the same time, the high incidence of urethral tumors in elderly and senile patients, as well as high postoperative complication rates, all contribute to the development of organ-preserving therapy. A case study to determine the organ-preserving therapy applicability in urethral cancer. The treatment experience in a senile patient with concomitant chronic kidney disease at the Volgograd Regional Clinical Oncology Dispensary's Oncology Unit was detailed in this article. Renal function was assessed in a postoperative period with dynamic nephroscintigraphy and blood creatinine testing. According to a follow-up, there is no evidence of disease relapse or progression in this patient group. The patient's improved renal function and sustained high quality of life in both immediate and long-term trials, as well as continued good quality of life.
Source link: https://doi.org/10.24060/2076-3093-2021-11-4-323-327
* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions